|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1999-12-8
|
|
pubmed:abstractText |
Interferon-beta (IFN-beta) is a widely used therapy for multiple sclerosis (MS), a demyelinating disease of the central nervous system. This study has evaluated the effect on thyroid function and autoimmunity of a 1-year treatment with IFN-beta1b in patients with MS.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0804-4643
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
141
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-31
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10526243-Adjuvants, Immunologic,
pubmed-meshheading:10526243-Adult,
pubmed-meshheading:10526243-Autoimmunity,
pubmed-meshheading:10526243-Female,
pubmed-meshheading:10526243-Follow-Up Studies,
pubmed-meshheading:10526243-Humans,
pubmed-meshheading:10526243-Interferon-beta,
pubmed-meshheading:10526243-Male,
pubmed-meshheading:10526243-Middle Aged,
pubmed-meshheading:10526243-Multiple Sclerosis, Relapsing-Remitting,
pubmed-meshheading:10526243-Recombinant Proteins,
pubmed-meshheading:10526243-Risk Factors,
pubmed-meshheading:10526243-Thyroid Gland,
pubmed-meshheading:10526243-Treatment Outcome
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Effect of 1-year treatment with interferon-beta1b on thyroid function and autoimmunity in patients with multiple sclerosis.
|
|
pubmed:affiliation |
Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
